Chernajovsky Y - Search Results

1

Gene therapy for chronic relapsing experimental allergic encephalomyelitis using cells expressing a novel soluble p75 dimeric TNF receptor.

Croxford JL, Triantaphyllopoulos KA, Neve RM, Feldmann M, Chernajovsky Y, Baker D. Croxford JL, et al. Among authors: chernajovsky y. J Immunol. 2000 Mar 1;164(5):2776-81. doi: 10.4049/jimmunol.164.5.2776. J Immunol. 2000. PMID: 10679120

2

Cloning and expression of murine IFN beta and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis.

Triantaphyllopoulos K, Croxford J, Baker D, Chernajovsky Y. Triantaphyllopoulos K, et al. Among authors: chernajovsky y. Gene Ther. 1998 Feb;5(2):253-63. doi: 10.1038/sj.gt.3300570. Gene Ther. 1998. PMID: 9578846

3

Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system.

Croxford JL, Triantaphyllopoulos K, Podhajcer OL, Feldmann M, Baker D, Chernajovsky Y. Croxford JL, et al. Among authors: chernajovsky y. J Immunol. 1998 May 15;160(10):5181-7. J Immunol. 1998. PMID: 9590271

4

Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system.

Croxford JL, Feldmann M, Chernajovsky Y, Baker D. Croxford JL, et al. Among authors: chernajovsky y. J Immunol. 2001 Mar 15;166(6):4124-30. doi: 10.4049/jimmunol.166.6.4124. J Immunol. 2001. PMID: 11238662

5

Transfection of thyroid autoantigens into EBV-transformed B cell lines. Recognition by Graves' disease thyroid T cells.

Mullins RJ, Chernajovsky Y, Dayan C, Londei M, Feldmann M. Mullins RJ, et al. Among authors: chernajovsky y. J Immunol. 1994 Jun 1;152(11):5572-80. J Immunol. 1994. PMID: 8189073

6

Expression of an efficient small molecular weight tumour necrosis factor/lymphotoxin antagonist.

Neve R, Kissonerghis M, Clark J, Feldmann M, Chernajovsky Y. Neve R, et al. Among authors: chernajovsky y. Cytokine. 1996 May;8(5):365-70. doi: 10.1006/cyto.1996.0050. Cytokine. 1996. PMID: 8726664

7

Gene therapy for rheumatoid arthritis. Theoretical considerations.

Chernajovsky Y, Annenkov A, Herman C, Triantaphyllopoulos K, Gould D, Dreja H, Moyes SP, Croxford JL, Mageed RA, Podhajcer OL, Baker D. Chernajovsky Y, et al. Drugs Aging. 1998 Jan;12(1):29-41. doi: 10.2165/00002512-199812010-00004. Drugs Aging. 1998. PMID: 9467685 Review.

8

Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy.

Triantaphyllopoulos KA, Williams RO, Tailor H, Chernajovsky Y. Triantaphyllopoulos KA, et al. Among authors: chernajovsky y. Arthritis Rheum. 1999 Jan;42(1):90-9. doi: 10.1002/1529-0131(199901)42:1<90::AID-ANR12>3.0.CO;2-A. Arthritis Rheum. 1999. PMID: 9920019 Free article.

9

The murine p75 TNF receptor promoter region: DNA sequence and characterization of a cis-acting silencer.

Kissonerghis M, Daly G, Feldmann M, Chernajovsky Y. Kissonerghis M, et al. Among authors: chernajovsky y. Mol Immunol. 1999 Feb;36(2):125-34. doi: 10.1016/s0161-5890(99)00022-x. Mol Immunol. 1999. PMID: 10378684

10

The activity of immunoregulatory T cells mediating active tolerance is potentiated in nonobese diabetic mice by an IL-4-based retroviral gene therapy.

Yamamoto AM, Chernajovsky Y, Lepault F, Podhajcer O, Feldmann M, Bach JF, Chatenoud L. Yamamoto AM, et al. Among authors: chernajovsky y. J Immunol. 2001 Apr 15;166(8):4973-80. doi: 10.4049/jimmunol.166.8.4973. J Immunol. 2001. PMID: 11290776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters